WLTH thesis audit: the growth story checks out, but the math behind the $19 target does not

Asked (summary):
Is this investment thesis on Wealthfront Corp (WLTH) valid, and should I invest in the company?

This audit checks 15 assertions from the bullish write-up against 105 sourced rows gathered on September 28, 2026: 30 company financial and operating facts (the latest-quarter figures are single-sourced at the underlying disclosure level — many hosts reproduce the same Wealthfront earnings release), 35 dated market-quote and analyst-estimate rows, and 40 claim assessments. Verdict: 5 claims supported, 3 mixed, 4 incorrect, 3 forecasts presented as fact — not a basis for a full-sized purchase.

Thesis scorecard: 15 claims, click any row for the evidence

Colour carries the verdict, not the topic: green means the current disclosures support the claim, amber means the evidence is mixed, red means the claim is arithmetically or factually wrong, and blue-violet means it is a forecast or unproven assumption, not a demonstrated fact.

Supported Mixed Incorrect Forecast / unproven

The two numbers that break the write-up

Share count: 174M x $10.18 is not $1.588B

Valuation: about 7.5x EV/run-rate adjusted EBITDA, not 11.8x

Q2 FY2027 versus Q1: operating growth, flat financials

Company-reported figures for the quarters ended April 30 and July 31, 2026. Assets in USD billions, everything else in USD millions except clients.

What the visuals cannot say

Cash management was 67.2% of Q2 revenue, not the post's ~75%, and its fee rate fell about 6 basis points year over year to roughly 55 bps — per-dollar economics are not unchanged. ir.wealthfront.com

Buybacks of $60.099M over six months did not shrink the share count: shares outstanding rose from 150.305M on January 31 to 150.749M on July 31, while diluted weighted-average shares were 174.052M. stocktitan.net

Recent consensus was Hold with a $12.14 average 12-month target versus a $10.18 price, and analysts expect $0.41 EPS this fiscal year — the $19 target at 22x needs roughly $0.86. marketbeat.com

Insiders including the CFO ($773,054) sold roughly $1.35M of stock in mid-September under pre-arranged 10b5-1 plans — a sentiment overhang, not a proof of anything. americanbankingnews.com

Claim-by-claim table

Claim in the postVerdictWhat the data showsSource

Method: audit of a bullish WLTH write-up against 105 sourced rows collected September 28, 2026 — 30 company financial/operating facts (Q1 and Q2 FY2027 releases; latest-quarter figures single-sourced at the disclosure level), 35 market-quote and analyst-estimate rows (dates and values differ by host; secondary sources), and 40 claim assessments with one URL each. Values in USD millions unless noted; platform assets in USD billions; fees in basis points. Run-rate EBITDA annualizes one quarter (4 x $38.065M) and is not a forecast; adjusted EBITDA excludes $16.4M of quarterly stock compensation. The 40 assessment rows were condensed into 15 scorecard claims; duplicate syndicated rows were cut for space. General research, not personalized fiduciary advice.

This report was generated automatically by Keenable SELECT at a user's request, from publicly available web sources linked herein. Keenable does not review, verify, or endorse its contents and makes no representation as to accuracy, completeness, or timeliness; AI-based extraction may contain errors. Nothing in this report is investment, legal, financial, or other professional advice. All trademarks and referenced content remain the property of their respective owners; no affiliation or endorsement is implied. To report an error, rights concern, or request removal: legal@keenable.ai.

Keenable SELECTAsk your own question
Made with Keenable SELECT